491 related articles for article (PubMed ID: 34053243)
1. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy.
Kang Y; Kang X; Zhang H; Liu Q; Yang H; Fan W
ASN Neuro; 2021; 13():17590914211016217. PubMed ID: 34053243
[TBL] [Abstract][Full Text] [Related]
2. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
5. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
[TBL] [Abstract][Full Text] [Related]
7. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
9. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
Dong S; Sun M; He C; Cheng H
Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
[TBL] [Abstract][Full Text] [Related]
10. Microbial treatment: the potential application for Parkinson's disease.
Fang X
Neurol Sci; 2019 Jan; 40(1):51-58. PubMed ID: 30415447
[TBL] [Abstract][Full Text] [Related]
11. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design.
Cheng Y; Tan G; Zhu Q; Wang C; Ruan G; Ying S; Qie J; Hu X; Xiao Z; Xu F; Chen L; Chen M; Pei Y; Zhang H; Tian Y; Chen D; Liu X; Huang H; Wei Y
Gut Microbes; 2023 Dec; 15(2):2284247. PubMed ID: 38057970
[TBL] [Abstract][Full Text] [Related]
13. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
Front Immunol; 2022; 13():937555. PubMed ID: 35812394
[TBL] [Abstract][Full Text] [Related]
15. Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype?
Van Laar T; Boertien JM; Herranz AH
J Parkinsons Dis; 2019; 9(s2):S371-S379. PubMed ID: 31609702
[TBL] [Abstract][Full Text] [Related]
16. [Advances in fecal microbiota transplantation for treatment of Parkinson's disease].
Zhang M; Wang H; Xue L; Yang X
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3812-3819. PubMed ID: 34841786
[TBL] [Abstract][Full Text] [Related]
17. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation.
Kuai XY; Yao XH; Xu LJ; Zhou YQ; Zhang LP; Liu Y; Pei SF; Zhou CL
Microb Cell Fact; 2021 May; 20(1):98. PubMed ID: 33985520
[TBL] [Abstract][Full Text] [Related]
20. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
